UnitedHealth Group
UNH (NYSE)
UnitedHealth Group is positioned for growth heading into 2026, supported by stabilizing medical costs and an anticipated earnings growth of 8%. Despite a challenging year with a 1-year return of -47.99%, the stock offers a dividend yield of approximately 2.70%, appealing to income-focused investors. Analysts maintain a positive outlook, with a median price target of $408.50, indicating potential upside.
Pros:
- Positioned for growth in 2026
- Stabilizing medical costs
Cons:
- Significant one-year decline
- Market volatility risk
UnitedHealth Group (UNH) may be suitable for long-term investors who are willing to weather short-term volatility and are seeking income through dividends, given its current yield of 2.70%. With analysts projecting a rebound and earnings growth of 8% by 2026, those with a growth-oriented strategy might also find potential value in the stock's future performance, despite its recent declines.